Another pathway that can be engaged by the HMGB1/RAGE axis is PI3K/Akt, as it contributes to gemcitabine resistance in pancreatic cancer by promoting protective autophagy and upregulating the expression of the multidrug resistance protein MDR1. Here, HMGB1 is linked to pancreatic neoplasm.